DARU-Journal of Pharmaceutical Sciences

Papers
(The TQCC of DARU-Journal of Pharmaceutical Sciences is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Hybrid derivatives containing dimethyl fumarate and benzothiazole scaffolds for the potential treatment of multiple sclerosis; in silico & in vivo study45
Multi-functionalization of reduced graphene oxide nanosheets for tumor theragnosis: Synthesis, characterization, enzyme assay, in-silico study, radiolabeling and in vivo targeting evaluation34
New psychoactive substances: a multidisciplinary review of challenges and their diverse character22
Dispersive micro-solid phase extraction based on two MOFs as highly effective adsorbents for analysis of nilotinib in plasma and wastewater19
Effect of vitamins C and E on cancer survival; a systematic review19
Colistin induced acute kidney injury in critically ill children: a prospective study utilizing RIFLE criteria17
Co-delivery of SN38 and rapamycin albumin bound nanoparticles against breast Cancer17
Management and control of intraocular pressure applying macitentan hydrogel film formulation: improved effect of surfactant and cosurfactant system16
Lipid nanoparticles for gene therapy in ocular diseases16
Successful treatment of acute-on-chronic liver failure secondary to alcoholic cirrhosis with glucocorticoids and albumin: a case report14
Impact of concerning excipients on animal safety: insights for veterinary pharmacotherapy and regulatory considerations13
Pharmacogenetic DPYD allele variant frequencies: A comprehensive analysis across an ancestrally diverse Iranian population13
Investigation of the potential therapeutic effect of cationic lipoplex mediated fibroblast growth factor-2 encoding plasmid DNA delivery on wound healing13
Oral regimen for high dose methotrexate urine alkalinization: a systematic review and meta-analysis13
Novel benzimidazole derivatives; synthesis, bioactivity and molecular docking study as potent urease inhibitors13
Stearyl amine tailored spanlastics embedded within tetronic® nanogel for boosting the repurposed anticancer potential of mebendazole: formulation, in vitro profiling, cytotoxicity assessment, and in v13
Structure based exploration of mitochondrial alpha carbonic anhydrase inhibitors as potential leads for anti-obesity drug development12
A comparison between SARS-CoV-1 and SARS-CoV2: an update on current COVID-19 vaccines11
Repurposing metformin as a potential anticancer agent using in silico technique11
Co-delivery of artemisinin and metformin via PEGylated niosomal nanoparticles: potential anti-cancer effect in treatment of lung cancer cells11
Cleaning validation in pharmaceutical quality control laboratories: a structured protocol for contamination risk mitigation11
The impact of Rosa dmascena Mill. on gastrointestinal disorders: a comprehensive analysis through clinical trials, systematic review, and meta-analysis11
Empowering the pharmaceutical industry by revolutionizing education10
Comparative evaluation of different oral iron salts in the management of iron deficiency anemia10
Ropivacaine suppresses the progression of renal cell carcinoma through regulating the lncRNA RMRP/EZH2/CCDC65 axis9
Designing and psychometric evaluation of pharmacists' attitude toward ethical challenges questionnaire in pharmacy practice: A mixed‑method study8
High-performance liquid chromatography method for measuring Captopril: an empirical study on hydrogel film permeability test8
Electrochemical evaluation of nivolumab used in cancer treatment with differential pulse voltammetry: A novel approach with single-use pencil graphite electrode8
Vancomycin- induced leukocytoclastic vasculitis in a patient with end-stage renal disease: a case report and literature review8
Computational Screening Using a Combination of Ligand-Based Machine Learning and Molecular Docking Methods for the Repurposing of Antivirals Targeting the SARS-CoV-2 Main Protease8
Alpinumisoflavone against cancer pro-angiogenic targets: In silico, In vitro, and In ovo evaluation7
Developing an AI-based prediction model for anaphylactic shock from injection drugs using Japanese real-world data and chemical structure-based analysis7
Trends analysis and future study of the pharmaceutical industry field: a scoping review7
Correction: Flavonoid as possible therapeutic targets against COVID-19: a scoping review of in silico studies7
A neuroprotective dose of trehalose is harmless to metabolic organs: comprehensive histopathological analysis of liver, pancreas, and kidney6
Efficacy of dostarlimab in recurrent or advanced mismatch Repair-Deficient endometrial Cancer as a Single-Agent therapy: A systematic review and Meta-Analysis6
From code to cure: AI-Driven innovation in monoclonal antibody development6
Correction: Dexmedetomidine alleviates Hypoxia/reoxygenation-induced mitochondrial dysfunction in cardiomyocytes via activation of Sirt3/ Prdx3 pathway6
Network pharmacology: a systems perspective possible underpinning approach for oral cancer treatment6
Adrenergic receptors blockade alleviates dexamethasone-induced neurotoxicity in adult male Wistar rats: Distinct effects on β-arrestin2 expression and molecular markers of neural injury6
Imiquimod as a new treatment in refractory idiopathic granulomatous mastitis: report of two cases5
Pre-emptive hydrocortisone therapy in early septic shock: a double-blind, allocation-concealed, pilot randomized controlled trial5
Mesoporous silica coated SPIONs containing curcumin and silymarin intended for breast cancer therapy5
Structure-activity relationship of pharmacophores and toxicophores: the need for clinical strategy5
Fibroblast growth factor 2 reduces endoplasmic reticulum stress and apoptosis in in-vitro Non-Alcoholic Fatty Liver Disease model5
Effectiveness of epigallocatechin gallate nanoparticles on the in-vivo treatment of Alzheimer’s disease in a rat/mouse model: a systematic review5
Protective and therapeutic effects of Scutellaria baicalensis and its main active ingredients baicalin and baicalein against natural toxicities and physical hazards: a review of mechanisms5
0.052083015441895